Dr. Richard M. Levenson
Levenson, M.D., FCAP is
Principal at Brighton Consulting Group and
innovator and opinion-leader in biomedical imaging, pathology, and
A Board-certified pathologist and Fellow of the College of American Pathologists (FCAP), He’s been a consultant since 2009 and active in a variety of areas, including brain cooling technology for treatment of cardiac arrest, optical measurement of deep brain temperature and coagulometry, intra-operative surgical guidance, digital pathology, novel non-addicting analgesics, and advanced multispectral and alternative imaging technologies. He’s assisted with grant submissions to Federal and European agencies: during 2010, Richard helped obtain around one million dollars in federal tax credits, a DARPA and a Navy SBIR grant, and also helped craft a 2,100-patient European clinical trial proposal.
Previously, Richard served as VP for Research at Cambridge Research and Instrumentation (CRI), recently purchased by Caliper. While there, he helped secure Federal grants in such areas as total internal reflection microscopy, small-animal imaging, whole-slide scanning and segmentation software, multispectral imaging, and combined multispectral and birefringence imaging systems all of these involved collaboration with outstanding investigators at major academic institutions. The systems whose development these grants supported are now deployed in many clinical and preclinical research labs across academia and pharma. He is an inventor on a number of published and issued patents, and (actually) enjoys serving on multiple NIH grant review committees. He also served as Executive Chairman of the Board of Spectros Corp, a developer of industry-leading FDA-approved tissue oximetry devices.
Prior to moving to CRI, he was an Assistant Professor in the Pathology Department at Duke University, after which he held a research faculty appointment at Carnegie Mellon University. He continues to publish sporadically, helps organize and speak at conferences and workshops, and serves on the editorial board of a number of journals.
Richard authored Spectral Imaging and Pathology: Seeing More, and coauthored In vivo cancer targeting and imaging with semiconductor quantum dots, Insulin Rapidly Induces the Biosynthesis of Elongation Factor 2, Semiautomated Multiplexed Quantum Dot-Based in Situ Hybridization and Spectral Deconvolution, Multiplexing with Multispectral Imaging: From Mice to Microscopy, Visualization of Microscopy-Based Spectral Imaging Data from Multi-Label Tissue Sections, and Distinguished photons: increased contrast with multispectral in vivo fluorescence imaging.
His patents and patent applications include Spectral imaging of deep tissue, Classifying image features, High-efficiency multiple probe imaging system, Spectral imaging methods and systems, Tissue processing and assessment, Image classifier training, and Systems and methods for in-vivo optical imaging and measurement.
Richard earned his BA at Harvard University in 1974 and his MD at the University of Michigan Medical School in 1979. Visit his Facebook page. Read his LinkedIn profile. Follow his Twitter feed.